ZE PAK Valuation
Is ZEP undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ZEP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate ZEP's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate ZEP's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ZEP?
Other financial metrics that can be useful for relative valuation.
| What is ZEP's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | zł1.00b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.09x |
| Enterprise Value/EBITDA | 2.2x |
| PEG Ratio | -0.3x |
Price to Earnings Ratio vs Peers
How does ZEP's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.2x | ||
ENG Energa | 3.8x | n/a | zł3.9b |
TPE TAURON Polska Energia | 3.1x | 8.4% | zł5.2b |
IRL AB Inter RAO Lietuva | 3.5x | n/a | zł230.8m |
KGN Zespól Elektrocieplowni Wroclawskich KOGENERACJA | 2.5x | n/a | zł734.6m |
ZEP ZE PAK | 5.2x | -19.7% | zł1.0b |
Price-To-Earnings vs Peers: ZEP is expensive based on its Price-To-Earnings Ratio (5.2x) compared to the peer average (3.1x).
Price to Earnings Ratio vs Industry
How does ZEP's PE Ratio compare vs other companies in the European Electric Utilities Industry?
Price-To-Earnings vs Industry: ZEP is good value based on its Price-To-Earnings Ratio (5.2x) compared to the European Electric Utilities industry average (11.3x).
Price to Earnings Ratio vs Fair Ratio
What is ZEP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 5.2x |
| Fair PE Ratio | 3x |
Price-To-Earnings vs Fair Ratio: ZEP is expensive based on its Price-To-Earnings Ratio (5.2x) compared to the estimated Fair Price-To-Earnings Ratio (3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | zł19.70 | zł28.55 +44.9% | 5.4% | zł30.10 | zł27.00 | n/a | 2 |
| Apr ’25 | zł19.60 | zł28.55 +45.7% | 5.4% | zł30.10 | zł27.00 | n/a | 2 |
| Mar ’25 | zł20.00 | zł28.55 +42.8% | 5.4% | zł30.10 | zł27.00 | n/a | 2 |
| Feb ’25 | zł20.30 | zł28.55 +40.6% | 5.4% | zł30.10 | zł27.00 | n/a | 2 |
| Jan ’25 | zł21.60 | zł21.75 +0.7% | 13.1% | zł24.60 | zł18.90 | n/a | 2 |
| Dec ’24 | zł22.00 | zł21.75 -1.1% | 13.1% | zł24.60 | zł18.90 | n/a | 2 |
| Nov ’24 | zł19.60 | zł20.60 +5.1% | 19.4% | zł24.60 | zł16.60 | n/a | 2 |
| Oct ’24 | zł20.05 | zł20.60 +2.7% | 19.4% | zł24.60 | zł16.60 | n/a | 2 |
| Sep ’24 | zł19.60 | zł20.60 +5.1% | 19.4% | zł24.60 | zł16.60 | n/a | 2 |
| Aug ’24 | zł20.40 | zł20.60 +1.0% | 19.4% | zł24.60 | zł16.60 | n/a | 2 |
| Jul ’24 | zł19.10 | zł20.60 +7.9% | 19.4% | zł24.60 | zł16.60 | n/a | 2 |
| Jun ’24 | zł21.40 | zł20.60 -3.7% | 19.4% | zł24.60 | zł16.60 | n/a | 2 |
| May ’24 | zł23.00 | zł21.90 -4.8% | 12.3% | zł24.60 | zł19.20 | n/a | 2 |
| Apr ’24 | zł23.50 | zł21.90 -6.8% | 12.3% | zł24.60 | zł19.20 | zł19.60 | 2 |
| Mar ’24 | zł26.30 | zł21.90 -16.7% | 12.3% | zł24.60 | zł19.20 | zł20.00 | 2 |
| Feb ’24 | zł28.95 | zł21.90 -24.4% | 12.3% | zł24.60 | zł19.20 | zł20.30 | 2 |
| Jan ’24 | zł23.00 | zł21.90 -4.8% | 12.3% | zł24.60 | zł19.20 | zł21.60 | 2 |
| Dec ’23 | zł21.45 | zł21.65 +0.9% | 13.6% | zł24.60 | zł18.70 | zł22.00 | 2 |
| Nov ’23 | zł27.40 | zł25.65 -6.4% | 56.7% | zł40.20 | zł11.10 | zł19.60 | 2 |
| Oct ’23 | zł18.40 | zł25.65 +39.4% | 56.7% | zł40.20 | zł11.10 | zł20.05 | 2 |
| Sep ’23 | zł28.10 | zł25.65 -8.7% | 56.7% | zł40.20 | zł11.10 | zł19.60 | 2 |
| Aug ’23 | zł31.00 | zł25.65 -17.3% | 56.7% | zł40.20 | zł11.10 | zł20.40 | 2 |
| Jul ’23 | zł24.20 | zł25.65 +6.0% | 56.7% | zł40.20 | zł11.10 | zł19.10 | 2 |
| Jun ’23 | zł19.18 | zł19.50 +1.7% | 43.1% | zł27.90 | zł11.10 | zł21.40 | 2 |
| May ’23 | zł16.74 | zł21.15 +26.3% | 47.5% | zł31.20 | zł11.10 | zł23.00 | 2 |
| Apr ’23 | zł17.15 | zł21.15 +23.3% | 47.5% | zł31.20 | zł11.10 | zł23.50 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.